Endocarditis (Streptococcus sanguinis)

Overview


Plain-Language Overview

Endocarditis (Streptococcus sanguinis) is an infection of the heart's inner lining, particularly affecting the heart valves. This condition involves the growth of bacterial colonies on the valves, which can interfere with normal heart function. The infection primarily affects the cardiovascular system and can lead to serious complications like heart valve damage or heart failure. Symptoms often include fever, fatigue, and sometimes signs of embolism if infected material breaks off. It is caused by bacteria that normally live in the mouth, such as Streptococcus sanguinis, entering the bloodstream and attaching to damaged heart tissue.

Clinical Definition

Endocarditis (Streptococcus sanguinis) is a form of infective endocarditis characterized by colonization of heart valves or endocardial surfaces by the viridans group streptococci, particularly Streptococcus sanguinis. The core pathology involves the formation of vegetations composed of bacteria, fibrin, and inflammatory cells on damaged or prosthetic heart valves. This condition typically arises after transient bacteremia, often following dental procedures or poor oral hygiene, allowing bacteria to adhere to previously injured endothelium. The infection can cause valvular destruction, leading to regurgitation, heart failure, and systemic emboli. Diagnosis and management are critical due to the risk of severe complications including septic emboli and immune complex-mediated phenomena.

Inciting Event

  • Transient bacteremia following dental manipulation or oral trauma introduces Streptococcus sanguinis into circulation.

  • Damage to endocardium from turbulent blood flow or prior valve disease facilitates bacterial adherence.

  • Introduction of bacteria via intravenous lines or injections in drug users.

Latency Period

  • Subacute onset over days to weeks after bacteremia or dental procedure is typical for Streptococcus sanguinis endocarditis.

  • Symptoms may develop gradually due to slow bacterial growth and vegetation formation.

Diagnostic Delay

  • Nonspecific symptoms such as low-grade fever and malaise often lead to delayed suspicion.

  • Negative initial blood cultures if antibiotics were given prior to sampling can obscure diagnosis.

  • Overlap with other febrile illnesses may cause misattribution of symptoms.

  • Lack of classic peripheral stigmata in early disease delays clinical recognition.

Clinical Presentation


Signs & Symptoms

  • Fever is the most common presenting symptom due to systemic infection

  • Fatigue and malaise from chronic inflammation and infection

  • New or worsening heart murmur indicating valvular involvement

  • Embolic phenomena such as stroke, splenic infarcts, or petechiae

  • Night sweats and weight loss reflecting subacute infection course

History of Present Illness

  • Low-grade fever and fatigue progressing over weeks is common.

  • New or changing heart murmur indicates valvular involvement.

  • Night sweats and weight loss reflect systemic inflammation.

  • Embolic phenomena such as stroke or splinter hemorrhages may appear later.

Past Medical History

  • History of valvular heart disease including mitral valve prolapse or rheumatic fever.

  • Previous infective endocarditis increases risk of recurrence.

  • Recent dental procedures or poor oral hygiene are important antecedents.

  • Presence of prosthetic heart valves or intracardiac devices.

Family History

  • []

Physical Exam Findings

  • New or changing heart murmur, often a systolic regurgitant murmur due to valvular damage

  • Splinter hemorrhages under the fingernails or toenails indicating microvascular emboli

  • Janeway lesions, painless erythematous macules on palms and soles from septic emboli

  • Osler nodes, tender subcutaneous nodules on fingers or toes caused by immune complex deposition

  • Roth spots, retinal hemorrhages with pale centers seen on fundoscopic exam

Diagnostic Workup


Diagnostic Criteria

Diagnosis of endocarditis caused by Streptococcus sanguinis relies on the Duke criteria, which include major criteria such as positive blood cultures for typical organisms and evidence of endocardial involvement on echocardiography. Blood cultures must repeatedly isolate Streptococcus sanguinis to confirm the causative agent. Echocardiography, especially transesophageal echocardiogram (TEE), is essential to detect vegetations, abscesses, or new valvular regurgitation. Minor criteria include predisposing heart conditions, fever, vascular phenomena, and immunologic signs. A combination of these findings establishes a definitive diagnosis.

Pathophysiology


Key Mechanisms

  • Bacterial colonization of damaged or abnormal heart valves by Streptococcus sanguinis via adherence to platelet-fibrin thrombi.

  • Formation of vegetations composed of bacteria, fibrin, and platelets on the endocardial surface leading to local tissue destruction.

  • Immune complex deposition causing systemic manifestations such as glomerulonephritis and vasculitis.

  • Continuous bacteremia from vegetations leading to septic emboli and metastatic infections.

InvolvementDetails
Organs

Heart is the primary organ affected, with infection of the valves leading to valvular dysfunction and potential heart failure.

Tissues

Endocardium is the tissue lining the heart valves where vegetations form due to bacterial colonization and thrombus formation.

Cells

Neutrophils are the primary immune cells that infiltrate infected heart valves to phagocytose Streptococcus sanguinis.

Platelets contribute to vegetation formation by aggregating at sites of endothelial injury on heart valves.

Chemical Mediators

C-reactive protein (CRP) is elevated as an acute phase reactant reflecting systemic inflammation in infective endocarditis.

Interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α) mediate inflammatory responses contributing to tissue damage in infected valves.

Treatments


Pharmacological Treatments

  • Penicillin G

    • Mechanism:
      • Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to bacterial lysis.

    • Side effects:
      • Allergic reactions

      • Nephrotoxicity

      • Neurotoxicity

    • Clinical role:
      • First-line

  • Gentamicin

    • Mechanism:
      • Binds to the 30S ribosomal subunit, causing misreading of mRNA and inhibiting bacterial protein synthesis.

    • Side effects:
      • Nephrotoxicity

      • Ototoxicity

      • Neuromuscular blockade

    • Clinical role:
      • Adjunctive

  • Vancomycin

    • Mechanism:
      • Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of cell wall precursors.

    • Side effects:
      • Red man syndrome

      • Nephrotoxicity

      • Ototoxicity

    • Clinical role:
      • Second-line

Non-pharmacological Treatments

  • Surgical valve repair or replacement is indicated in cases of heart failure, uncontrolled infection, or large vegetations causing embolic risk.

  • Supportive care includes management of heart failure symptoms and monitoring for embolic complications.

Prevention


Pharmacological Prevention

  • Prophylactic antibiotics such as amoxicillin before dental procedures in high-risk patients

  • Use of targeted antibiotic regimens to eradicate oral streptococci in at-risk individuals

  • Antimicrobial mouth rinses to reduce oral bacterial load in susceptible patients

Non-pharmacological Prevention

  • Maintaining good oral hygiene to reduce Streptococcus sanguinis colonization

  • Regular dental check-ups and prompt treatment of dental infections

  • Avoidance of unnecessary invasive procedures in patients with known valvular disease

  • Screening and monitoring of patients with prosthetic valves or congenital heart disease

  • Education on recognizing early symptoms to ensure timely medical evaluation

Outcome & Complications


Complications

  • Valvular destruction leading to heart failure from severe regurgitation

  • Septic emboli causing stroke or systemic infarcts

  • Perivalvular abscess formation causing conduction abnormalities

  • Glomerulonephritis due to immune complex deposition

  • Persistent bacteremia leading to metastatic infections such as osteomyelitis

Short-term Sequelae Long-term Sequelae
  • Acute heart failure from rapid valvular insufficiency

  • Septic embolic events causing transient ischemic attacks or infarcts

  • Persistent fever and bacteremia despite initial treatment

  • Conduction abnormalities from perivalvular abscesses

  • Acute kidney injury secondary to immune complex glomerulonephritis

  • Chronic valvular insufficiency requiring surgical valve repair or replacement

  • Recurrent endocarditis especially if predisposing factors persist

  • Permanent neurological deficits from embolic strokes

  • Chronic kidney disease from glomerulonephritis

  • Heart failure due to progressive valvular damage

Differential Diagnoses


Endocarditis (Streptococcus sanguinis) versus Infective Endocarditis due to Staphylococcus aureus

Endocarditis (Streptococcus sanguinis)

Infective Endocarditis due to Staphylococcus aureus

Gram-positive cocci in chains, part of viridans group streptococci causing subacute infection

Gram-positive cocci in clusters, often causing acute, aggressive infection

Subacute onset with low-grade fever and insidious symptoms

Rapid onset with high fever and systemic toxicity

Commonly follows dental procedures or poor dental hygiene

Often associated with intravenous drug use or healthcare exposure

Endocarditis (Streptococcus sanguinis) versus Infective Endocarditis due to Enterococcus species

Endocarditis (Streptococcus sanguinis)

Infective Endocarditis due to Enterococcus species

Gram-positive cocci in chains, sensitive to penicillin and associated with oral flora

Gram-positive cocci in pairs and short chains, often resistant to many antibiotics

Typically linked to dental procedures or oral mucosal disruption

Frequently linked to genitourinary or gastrointestinal procedures

Usually treated effectively with penicillin or ceftriaxone monotherapy

Often requires combination antibiotic therapy due to resistance

Endocarditis (Streptococcus sanguinis) versus Nonbacterial Thrombotic Endocarditis (NBTE)

Endocarditis (Streptococcus sanguinis)

Nonbacterial Thrombotic Endocarditis (NBTE)

Vegetations containing bacteria and inflammatory cells

Sterile vegetations composed of fibrin and platelets without microorganisms

Symptomatic with fever and positive blood cultures

Often associated with malignancy or hypercoagulable states, usually asymptomatic until embolization

Positive blood cultures for viridans streptococci

Negative blood cultures despite evidence of vegetations on echocardiogram

Endocarditis (Streptococcus sanguinis) versus Rheumatic Heart Disease

Endocarditis (Streptococcus sanguinis)

Rheumatic Heart Disease

No preceding streptococcal pharyngitis, often related to dental flora

History of untreated group A streptococcal pharyngitis weeks prior

Presence of vegetations on valve leaflets

Chronic valvular scarring and deformity without vegetations

Infectious process with systemic signs of infection

Chronic progressive valvular dysfunction with possible heart failure

Endocarditis (Streptococcus sanguinis) versus Libman-Sacks Endocarditis

Endocarditis (Streptococcus sanguinis)

Libman-Sacks Endocarditis

Infectious vegetations on valve leaflets caused by bacteria

Sterile, verrucous vegetations on both sides of valve leaflets associated with autoimmune disease

No autoimmune association, caused by oral streptococcal infection

Associated with systemic lupus erythematosus and antiphospholipid syndrome

Positive blood cultures for Streptococcus sanguinis

Negative blood cultures and positive autoimmune serologies

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.